← Insider buys
REPL

Replimune Group, Inc. · Healthcare

Chief Business Officer Pamela Esposito sold $577K of Replimune Group, Inc.

Sold$576,575
$33.14Price
17,400Shares
−8%Stake

What REPL did after the filing

Prices for REPL after this filing aren't in yet.

Traded Tue, Jul 20. Filed Thu, Jul 22, 5:01 PM ET, after the close. Not investment advice.